These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 12450696)
1. Induction of hepatitis C virus-specific cytotoxic T lymphocytes in mice by immunization with dendritic cells transduced with replication-defective recombinant adenovirus. Matsui M; Moriya O; Abdel-Aziz N; Matsuura Y; Miyamura T; Akatsuka T Vaccine; 2002 Dec; 21(3-4):211-20. PubMed ID: 12450696 [TBL] [Abstract][Full Text] [Related]
2. Enhanced induction of hepatitis C virus-specific cytotoxic T lymphocytes and protective efficacy in mice by DNA vaccination followed by adenovirus boosting in combination with the interleukin-12 expression plasmid. Matsui M; Moriya O; Akatsuka T Vaccine; 2003 Apr; 21(15):1629-39. PubMed ID: 12639484 [TBL] [Abstract][Full Text] [Related]
3. Induction of hepatitis C virus-specific cytotoxic T lymphocytes in mice by immunization with dendritic cells treated with an anthrax toxin fusion protein. Moriya O; Matsui M; Osorio M; Miyazawa H; Rice CM; Feinstone SM; Leppla SH; Keith JM; Akatsuka T Vaccine; 2001 Dec; 20(5-6):789-96. PubMed ID: 11738742 [TBL] [Abstract][Full Text] [Related]
4. Induction of Tc1 response and enhanced cytotoxic T lymphocyte activity in mice by dendritic cells transduced with adenovirus expressing HBsAg. Huang Y; Chen Z; Jia H; Wu W; Zhong S; Zhou C Clin Immunol; 2006 Jun; 119(3):280-90. PubMed ID: 16531121 [TBL] [Abstract][Full Text] [Related]
5. Induction of hepatitis C virus-specific cytotoxic T and B cell responses by dendritic cells expressing a modified antigen targeting receptor. Wang QC; Feng ZH; Zhou YX; Nie QH World J Gastroenterol; 2005 Jan; 11(4):557-60. PubMed ID: 15641145 [TBL] [Abstract][Full Text] [Related]
7. Induction of anti-tumor immunity by dendritic cells transduced with FAT10 recombinant adenovirus in mice. Yang Z; Wu D; Zhou D; Jiao F; Yang W; Huan Y Cell Immunol; 2015 Jan; 293(1):17-21. PubMed ID: 25461613 [TBL] [Abstract][Full Text] [Related]
8. Adjuvant activities of novel cytokines, interleukin-23 (IL-23) and IL-27, for induction of hepatitis C virus-specific cytotoxic T lymphocytes in HLA-A*0201 transgenic mice. Matsui M; Moriya O; Belladonna ML; Kamiya S; Lemonnier FA; Yoshimoto T; Akatsuka T J Virol; 2004 Sep; 78(17):9093-104. PubMed ID: 15308705 [TBL] [Abstract][Full Text] [Related]
9. Enhanced T cell responses against hepatitis C virus by ex vivo targeting of adenoviral particles to dendritic cells. Echeverria I; Pereboev A; Silva L; Zabaleta A; Riezu-Boj JI; Bes M; Cubero M; Borras-Cuesta F; Lasarte JJ; Esteban JI; Prieto J; Sarobe P Hepatology; 2011 Jul; 54(1):28-37. PubMed ID: 21452282 [TBL] [Abstract][Full Text] [Related]
10. Prophylactic DNA vaccine for hepatitis C virus (HCV) infection: HCV-specific cytotoxic T lymphocyte induction and protection from HCV-recombinant vaccinia infection in an HLA-A2.1 transgenic mouse model. Arichi T; Saito T; Major ME; Belyakov IM; Shirai M; Engelhard VH; Feinstone SM; Berzofsky JA Proc Natl Acad Sci U S A; 2000 Jan; 97(1):297-302. PubMed ID: 10618412 [TBL] [Abstract][Full Text] [Related]
11. DNA immunization with hepatitis C virus (HCV) polycistronic genes or immunization by HCV DNA priming-recombinant canarypox virus boosting induces immune responses and protection from recombinant HCV-vaccinia virus infection in HLA-A2.1-transgenic mice. Pancholi P; Perkus M; Tricoche N; Liu Q; Prince AM J Virol; 2003 Jan; 77(1):382-90. PubMed ID: 12477843 [TBL] [Abstract][Full Text] [Related]
12. Generation of cytotoxic T cell against HBcAg using retrovirally transduced dendritic cells. Ding CL; Yao K; Zhang TT; Zhou F; Xu L; Xu JY World J Gastroenterol; 2003 Jul; 9(7):1512-5. PubMed ID: 12854153 [TBL] [Abstract][Full Text] [Related]
13. Vaccination against hepatitis C virus with dendritic cells transduced with an adenovirus encoding NS3 protein. Zabaleta A; Llopiz D; Arribillaga L; Silva L; Riezu-Boj JI; Lasarte JJ; Borrás-Cuesta F; Prieto J; Sarobe P Mol Ther; 2008 Jan; 16(1):210-7. PubMed ID: 17923840 [TBL] [Abstract][Full Text] [Related]
14. Development of a dendritic cell vaccine encoding multiple cytotoxic T lymphocyte epitopes targeting hepatitis C virus. Zhou Y; Zhao F; Chen L; Ma L; Wang Y; He Y; Ma Z; Liu H; Guo Y; Zhang Y; Yao Z; Hao C; Jia Z Int J Mol Med; 2013 Oct; 32(4):901-9. PubMed ID: 23934073 [TBL] [Abstract][Full Text] [Related]
15. Genetic immunization of wild-type and hepatitis C virus transgenic mice reveals a hierarchy of cellular immune response and tolerance induction against hepatitis C virus structural proteins. Satoi J; Murata K; Lechmann M; Manickan E; Zhang Z; Wedemeyer H; Rehermann B; Liang TJ J Virol; 2001 Dec; 75(24):12121-7. PubMed ID: 11711603 [TBL] [Abstract][Full Text] [Related]
16. Vaccination with an adenoviral vector encoding hepatitis C virus (HCV) NS3 protein protects against infection with HCV-recombinant vaccinia virus. Arribillaga L; de Cerio AL; Sarobe P; Casares N; Gorraiz M; Vales A; Bruna-Romero O; Borrás-Cuesta F; Paranhos-Baccala G; Prieto J; Ruiz J; Lasarte JJ Vaccine; 2002 Dec; 21(3-4):202-10. PubMed ID: 12450695 [TBL] [Abstract][Full Text] [Related]
17. Dendritic cells transfected with PEG10 recombinant adenovirus elicit anti-tumor immune response in vitro and in vivo. Peng W; Zhao G; Ma Y; Yu H; Wang X Vaccine; 2011 Apr; 29(18):3501-6. PubMed ID: 21352943 [TBL] [Abstract][Full Text] [Related]
18. Long-term humoral and cellular immunity induced by a single immunization with replication-defective adenovirus recombinant vector. Juillard V; Villefroy P; Godfrin D; Pavirani A; Venet A; Guillet JG Eur J Immunol; 1995 Dec; 25(12):3467-73. PubMed ID: 8566039 [TBL] [Abstract][Full Text] [Related]
19. Enhancement of CTLs induced by DCs loaded with ubiquitinated hepatitis B virus core antigen. Chen JH; Yu YS; Chen XH; Liu HH; Zang GQ; Tang ZH World J Gastroenterol; 2012 Mar; 18(12):1319-27. PubMed ID: 22493545 [TBL] [Abstract][Full Text] [Related]
20. Enhanced and sustained CD8+ T cell responses with an adenoviral vector-based hepatitis C virus vaccine encoding NS3 linked to the MHC class II chaperone protein invariant chain. Mikkelsen M; Holst PJ; Bukh J; Thomsen AR; Christensen JP J Immunol; 2011 Feb; 186(4):2355-64. PubMed ID: 21257961 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]